Journal of the Chinese Medical Association
Volume 71, Issue 10 , Pages 509-516, October 2008

Behcet's Disease with Uveitis in Taiwan

  • Yu-Mei Chung

      Affiliations

    • Uveitis Service, Department of Ophthalmology, Taipei, Taiwan, R.O.C.
    • Corresponding Author InformationCorrespondence to: Dr Yu-Mei Chung, Uveitis Service, Department of Ophthalmology, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C.
    • ,
  • Ying-Cheng Lin

      Affiliations

    • Department of Ophthalmology, Taipei City Hospital Yang-Ming Branch, Taipei, Taiwan, R.O.C.
    • ,
  • Chia-Chen Tsai

      Affiliations

    • Department of Ophthalmology, Cheng Hsin General Hospital, Taipei, Taiwan, R.O.C.
    • ,
  • De-Feng Huang

      Affiliations

    • Division of Allergy, Immunology and Rheumatology, Department of Medicine, National Yang-Ming University School of Medicine and Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.

Received 31 March 2008; accepted 23 September 2008.

Article Outline

Background

Behcet's disease is a multisystemic inflammatory disease which may lead to blindness. The purpose of this study was to describe and compare the clinical features and visual outcome of Behcet's uveitis in Taiwan.

Methods

The medical charts of 227 consecutive patients (414 eyes) with Behcet's uveitis who were seen in the Uveitis Clinic of Taipei Veterans General Hospital were reviewed: 96 patients (group A) between 1984 and 1993 and 131 (group B) between 1994 and 2003.

Results

The male-to-female ratio was 1.6. The mean age at the time of uveitis onset was 30.8 years. Males were most affected in the 3rd and 4th decades and females in the 2nd to 5th decades. There were more skin and gastrointestinal lesions in males, and less skin and genital lesions in group B. HLA-B51 antigen was found in 35.7% of patients. Treatment with cyclosporin, azathioprine and methotrexate was more frequent in group B. Uveitis occurred bilaterally in 83.9% of patients. At the first visit, potential visual acuity (VA) was 0.1 or less in 24.7% of eyes in males and 11.4% in females. The mean time from presentation to loss of useful vision (> 0.1) was 51 months in 19.1% of eyes. Kaplan-Meier survival analysis estimated the risks of losing useful vision at 5, 10 and 15 years as being 22.6%, 43.0% and 58.5%, respectively. VA at the first and last visits were better and VA deterioration slower in group B.

Conclusions

Visual outcome is poorer in males than in females and has improved in the recent decade, but still a significant proportion of patients lose their vision quickly. The number of new patients has not decreased.

Key Words:  Behcet's disease , Chinese , Taiwan , uveitis

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Verity DH , Marr JE , Ohno S , Wallace GR , Stanford MR . Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives . Tissue Antigens . 1999;54:213–220
  2. Mok CC , Cheung TC , Ho CTK , Lee KW , Lau CS , Wong RW . Behcet's disease in Southern Chinese patients . J Rheumotol . 2002;29:1689–1693
  3. Mineshita S, Tian D, Wang LM, Jian XY, Li SY, Fang GZ, et al  Histocompatibility antigens associated with Behcet's disease in northern Han Chinese . Intern Med . 1992;31:1073–1075
  4. Geng L , Ohno S , Wang YH , Higuchi M . Clinical observations on Behcet's disease in Tianjin, China . Jpn J Ophthalmol . 1985;29:310–314
  5. Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, et al  Clinical pattern and characteristics of uveitis in a tertiary center for uveitis in China . Curr Eye Res . 2005;30:943–948
  6. Chung YM , Yeh TS , Sheu MM , Chen MS , Wen MS , Tsai HY . Behcet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments . J Formos Med Assoc . 1990;89:413–417
  7. Kaklamani VG , Vaiopoulos G , Kaklamains PG . Behcet's disease . Semin Arthritis Rheu . 1998;27:197–217
  8. Fresko I . Highlight of the 10th International Congress on Behcet's Disease . Clin Exp Rheumatol . 2002;20(Suppl):S59–S64
  9. Yoshida A, Kawashima H, Motoyama Y, Shibui H, Kaburaki T, Shimizu K, et al  Comparison of patients with Behcet's disease in the 1980s and 1990s . Ophthalmology . 2004;111:810–815
  10. Tugal-Tutkun I , Onal S , Altan-Yaycioglu R , Altunbas HH , Urgancioglu AM . Uveitis in Behcet disease: an analysis of 880 patients . Am J Ophthalmol . 2004;138:373–380
  11. Suzuki Kurokawa M , Suzuki N . Behcet's disease . Clin Exp Med . 2004;4:10–20
  12. Chung YM , Yeh TS , Liu JH . Endogeous uveitis in Chinese: an analysis of 240 cases in a uveitis clinic . Jpn J Ophthalmol . 1988;32:64–69
  13. Behcet H . Uber rezidiverende, apthose durch ein Virus verusachte Geschwure am Mund, am auge und an der Genitalen . Dermatol Wochenschr . 1937;105:1152–1157 [In German]
  14. Adamantiades B . Sur un case d'iritis a hypopyon recidivant . Ann Oculist (Paris) . 1931;168:271–278 [In French]
  15. Feigenbaum A . Description of Behcet's syndrome in Hippocratic third book endemic disease . Br J Ophthalmol . 1956;40:355–357
  16. International Study Group for Behcet's Disease  . Evaluation of diagnostic (classification) criteria in Behcet's disease: toward internationally agreed criteria . Lancet . 1990;335:1078–1080
  17. Sakamoto M , Akazawa K , Nishioka Y , Sanui H , Inomata H , Nose Y . Prognostic factors of vision in patients with Behcet disease . Ophthalmology . 1995;102:317–321
  18. Muhaya M, Lightman S, Ikeda E, Mochizuki M, Shaer B, McCluskey P, et al. Behcet's disease in Japan and in Great Britain: a comparative study . Ocul Immunol Inflamm . 2000;8:141–148
  19. Ambresin A , Tran T , Spertini F , Herbort C . Behcet's disease in Western Switzerland: epidemiology and analysis of ocular involvement . Ocul Immunol Inflamm . 2002;10:53–63
  20. Takeuchi M, Hokama H, Tsukahara R, Kezuka T, Goto H, Sakai JI, et al. Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement . Grafes Arch Clin Exp Ophthalmol . 2005;243:1147–1152
  21. Ando K , Fujino Y , Hijikata K , Izawa Y , Masuda K . Epidemiological features and visual prognosis of Behcet's disease . Jpn J Ophthalmol . 1999;43:312–317
  22. Barra C , Belfort R , Abreu MT , Kim MK , Martins MC , Petrilli AM . Behcet's disease in Brazil: a review of 49 cases with emphasis on ophthalmic manifestations . Jpn J Ophthalmol . 1991;35:339–346
  23. Demiroglu H , Barista I , Dundar S . Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey . Ophthalmology . 1997;104:701–705
  24. Mishima S , Masuda K , Izawa Y , Mochizuki M , Namba K . Behcet's disease in Japan: ophthalmological aspects . Trans Am Ophthalmol Soc . 1979;77:225–279
  25. Shaw CK , Chen LL , Lee A , Lee TD . Distribution of HLA gene and haplotype frequencies in Taiwan: a comparative study among Min-nan, Hakka, Aborigines and Mainland Chinese . Tissue Antigens . 1999;53:51–64
  26. Matsumura N , Mizushima Y . Leucocyte movement and colchine treatment in Behcet's disease . Lancet . 1975;2:813
  27. Yurdakul S, Mat C, Tuzun Y, Ozyazgan Y, Hamuryudan V, Uysal O, et al  A double-blind trial of colchicine in Behcet's syndrome . Arthritis Rheum . 2001;44:2686–2692
  28. Nussenblatt RB , Palestine AG , Chan CC , Mochizuki M , Yancey K . Effectiveness of cyclosporin therapy for Behcet's disease . Arthritis Rheum . 1985;28:671–679
  29. Mamo FG . The rate of visual loss in Behcet's disease . Arch Ophthalmol . 1970;84:451–452
  30. BenEzra D , Cohen E . Treatment and visual prognosis in Behcet's disease . Br J Ophthalmol . 1986;70:589–592

PII: S1726-4901(08)70159-X

doi:10.1016/S1726-4901(08)70159-X

Journal of the Chinese Medical Association
Volume 71, Issue 10 , Pages 509-516, October 2008

Article Tools